[Elsevier] Efficacy and safety of obinutuzumab 汕 in patients with active systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial |
|
This post will be closed automatically in 2026-11-22 16:07
Reward10points
|
10
Toward Enhanced Energy Forecasting for Smart Grid Integration in Net Zero Energy Buildings
10
Granular ball feedforward network for fake news detection
10
Efficacy and safety of obinutuzumab 汕 in patients with active systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
10
DMGNet: Discriminative multi-view geometry learning with hybrid-domain enhancement for light field occlusion removal
10
Design, synthesis and biological evaluation of tanshinone IIA derivatives as NLRP3 inflammasome inhibitors